Pre-Market Gappers

In reaction to strong earnings/guidance: SPLS +8.8%, ATVI +8.3%, KOPN +4.9%, CTRN +3.5%, DCI +3.1%, CMRG +2.9%, TECD +2.5%, ESRX +2.0%, TECD +1.5%, AEO +1.3%... Financials showing strength following Abu Dhabi investment in Citi, positive BCS guidance: UBS +4.5%, C +4.0% (announces plans to sell $7.5 bln of equity units to Abu Dhabi investment authority for $7.5 bln), BCS +4.0% (gives guidance and seeks to reassure investors on earnings), LEH +2.6%, WFC +2.0%, GS +1.5%, MER +1.4%, JPM +1.2%, BAC +1.2%, WB +1.1%... Other news: BBND +11.9% (announces that five additional Chinese operators are deploying its Broadband Multimedia-Service router to process and deliver digital television services), KMP +5.6% (expects to declare cash distributions of $4.02 per unit for 2008), PHM +4.9% (reaffirms Q4 guidance), RIG +3.6% (UK regulators clear way for merger with GSF), BPHX +3.4% (positive comments from Roth), ACN. +3.3% (still checking), DKS +3.3% (agrees to acquire Chick's Sporting Goods; will be marginally accretive in FY08), AIV +2.8% (still checking), BRCD +1.9% (Cramer makes bullish comments on MadMoney), CFC +1.9% (Fox Pitt believes its unlikely that FHLB/Atlanta will stop lending to CFC), THQI +1.8% (announces resignation of Chief Financial Officer), KBH +1.8% (up in sympathy with PHM and initiated with Hold at Soleil), GSK +1.6% (obtains exclusive US OTC marketing rights to Mevacor from MRK), MON +1.6% (still checking), NOC +1.6% (received follow-up contract from US Army valued at $20 mln), CI +1.5% (announces it signed agreement to acquire Great-West Healthcare for $1.5 bln; accretive FY08), BMY +1.4% (still checking), CPT +1.4% (replacing APPB in S&P MidCap 400), IDT +1.4% (announces its subsidiary Net2Phone wins arbitration against Altice), YGE +1.4% (signs $56 mln silicon furnace contract with GTSolar)... Analyst upgrades: MRO +2.4% (upgraded to Peer Perform at Bear Sterns), MYL +2.0% (hearing upgraded to Buy at tier-1 firm), PBI +1.4% (initiated with Buy at BofA), AXA +1.4% (upgraded to Outperform at Credit Suisse), EFII +1.2% (initiated with Buy at BofA), BP +1.2% (upgraded to Outperform at Bear Sterns).